Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oral ENMD-2076 is effective in treatment of
patients with platinum resistant ovarian, fallopian, or peritoneal cancer. Additional sites
to be added.